Oncology Flashcards

1
Q

What are the 8 hallmarks of cancer

A
  • Sustained angiogenesisi
  • Evading apoptosis
  • Self sufficiency in growth signals
  • Insesntitivity to anti-growth signals
  • Tissue invasion and metastasis
  • Limitless replicative potential
  • Deregulating cellular metabolism
  • Immune evasion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the role of oncogenes and tumor supressor genes?

A
  • Overactive tumor promoting genes (oncogenes) - caused by mutation to proto-oncogene, required mutation in one allele (dominant)
  • Loss of tumor supressor genes - requires loss of both alleles (recessive)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the role of P53

A
  • Acts as a checkpoint gene to survey cellular DNA damage
  • Stops cell division when significant DNA damage is detected
  • Can trigger apoptosis
  • Loss of P53 is most common genetic alteration in human cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is epigenetics?

A
  • Gene function alteratiosn without changes to the DNA
  • Usually through changes in the regulatory elements (promotor or enhancer)
  • Linked to environemntal and acquired cancer risks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are telomeres

A
  • Specialised DNA protein complexes which cap chromosome ends and maintain stability
  • Tandem repeats of TTAGGG
  • Telomeres shorten with each division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is telomerase

A
  • Telomerase is a reverse transcriptase which extends telomeres giving cells proliferative potential
  • Cancer cells often have high telomerase levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 5 steps in the metastatic cascade?

A
  • Cellular basement membrane invasion and migration
  • Invasion of nearby vessels and lymphatics
  • Survival in circulation
  • Extravasation into new tissues
  • Proliferation in new site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is angiogenesis (in neoplasia) and what are some of the growth factors that contribute to it

A
  • Formation of new blood vessels within the tumor micorenvironment
  • Driven by: Hypoxia, VEGF (vascular endothelial growth factor), PDGF (platelet endothelial growth factor) and bFGF (basic fibroblast growth factor)
  • Many cancer cells can induce angiogenesis in absence of hypoxia by upregulating stimulatory cytockines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the cancer stem cell hypothesis?

A
  • This proposes there is a population of cells within tumors that account for the rapis recurrence of a cancer after initial response to therapy.
  • These cells are: slowly dividing, self renewing, resistant to conventional treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chemotherapy is most effective against small tumor burdens - due to what biological factors?

A

As tumors grow:
- growth fraction decreases
- cell time increases
- heterogenicity increases (leading to spontaneous resistance)
- areas of poor drug perfusion develop

Important because:
- Chemotherapy follows fractional kill kinetics
- Resistance occurs through spontaneous mutation which is correlated with number of cell divisions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name some alkylating agents and their broad mechanism of action

A
  • Cyclophosphamide, chlorambucil, melphalan, lomustine (CCNU)
  • Create cross-links in DNA causing strand breaks or DNA alkylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name some antitumor antibiotics (anthracyclines) and their broad mechanism of action

A
  • Doxorubicin, epirubicin, mitoxantrone
  • Intercalate DNA and interfere with topoisomerases
  • Are substrates for the multidrug resistance (MDR) pump (risk of resistance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name some Mitotitc inhibitors and their broad mechanism of action

A
  • block spindle assembly (vinca alkaloids - vinblastine, vincristine, vinorelbine)
  • or spindle stability (paclitaxel)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name some platinum agents and their broad mechanism of action

A

Cisplatin, carboplatin
Create DNA cross-links and strand breaking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name some antimetabolite agents and their broad mechanism of action

A
  • Rabacfosadine, gemcitabine, Cytosine arabinoside, methotrexate, 5FU
  • Nuceloside analogues or DNA enzyme inhbitors
  • Interfere with DNA synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the aims of a combination chemotherapy protocol

A
  • Target different tumor cellular metabolic pathways to overcome resistance
  • Maintain effectiveness without compounding toxicity
  • Avoidance of cross-resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the mechanism of action of radiotherapy

A

Damages DNA
- Photons cause direct ionisation (1/3)
- non-DNA ionisation causes free radicle ionisation (2/3)
- Cause strand breakage - DSB (double strand break) most effective for cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the 5 R’s in radiation biology

A
  • Repair: Radiation induces more repairable breaks than non-repairable, fractionation takes advantage of this
  • Redistribution: Fractionation allows cells to move between cycle phases of varying sensitivity
  • Repopulation: Tumour cells can regenerate during treatment (a common cause of failure)
  • Re-oxygenation: Fractionation improves oxygenation of hypoxic tumour areas, oxygenation of tissues improves effect of radiation
  • Radiosensitivity: Different cells have different radiosensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which immune cells are responsible for direct tumor cell killing

A

CD 8+ and NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the mechanism of action of toceranib

A

A multikinase inhibitor that acts on multiple receptor tyrosine kinases (RTKs)
* Direct action: inhibiting transmitting KIT signals with gain-of-function mutations.
* Indirect action: controlling angiogenesis through PDGFR and VEGFR inhibition
* It induces regulatory T cell suppression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are 3 main targets of toceranib

A

KIT,
Vascular endothelial growth factor receptor 2 (VEGFR2),
Platelet-derived growth factor receptor (PDGFR) beta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the main adverse effects of toceranib

A
  • Gastrointestinal toxicosis,
  • myelotoxicosis,
  • musculoskeletal disorders,
  • depigmentation
  • hypertension
  • hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which tumors respond to the direct action of Toceranib

A

Mast cell tumors (MCTs) and gastrointestinal stromal tumors (GISTs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the prevalence range of c-KIT mutations in canine MCTs

A

8-45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which tumor types respond better to Toceranib’s indirect actions

A

Epithelial malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the two classifications of chemotherapy drugs regarding extravasation potential

A

“Irritants” and “Vesicants”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

List four immediate management steps for any extravasation event

A

1) Stop drug administration immediately,
2) Apply gentle negative pressure to remove drug,
3) Remove the catheter gently,
4) Avoid occlusive bandaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Name examples of irritant chemotherapy drugs.

A

Platinum drugs (carboplatin, cisplatin),
dacarbazine,
mitoxantrone,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the typical effects of irritant drug extravasation

A

Mild to moderate erythema, edema, and crusting causing discomfort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Name examples of mild vesicant chemotherapy drugs

A

Vinca alkaloids (vincristine, vinblastine, vinorelbine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What compresses should be applied for mild vesicant extravasation?

A

Warm compresses for 15-20 minutes, every 6 hours, for 2-3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Name three examples of serious vesicant chemotherapy drugs

A

Anthracyclines (doxorubicin, epirubicin),
dactinomycin,
mechlorethamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What compresses should be applied for serious vesicant extravasation?

A

Cold compresses for 15-20 minutes, every 6 hours, for 2-3 days (opposite to mild vesicants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What specific antidote can be used for doxorubicin extravasation, and when must it be administered?

A

IV dexrazoxane (10× the doxorubicin dose) within 3 hours, repeated at 24 and 48 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

When do neutrophil nadirs typically occur post-chemotherapy treatment

A

5-10 days post-treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

When do platelet nadirs typically occur post-chemotherapy treatment

A

7-14 days post-treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Which genetic mutation increases risk of chemotherapy-induced myelosuppression in certain breeds?

A

Mutations in the ABCB1-1delta (MDR-1) gene

Collies, Australian Shepherds, and related breeds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Which chemotherapy agents most commonly cause clinically significant neutropenia in dogs and cats?

A

Carboplatin, doxorubicin, CCNU, mitoxantrone, vinblastine, and vinorelbine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Which chemotherapy agents commonly cause thrombocytopenia

A

Carboplatin, CCNU, dacarbazine, melphalan, dactinomycin, cytosine arabinoside, and doxorubicin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Which class of agents may cause cumulative and irreversible thrombocytopenia with chronic use

A

Alkylating agents (CCNU, chlorambucil, melphalan).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Which dog breeds are most susceptible to chemotherapy-induced alopecia

A

Continuously-growing hair breeds: Maltese, Bichon Frisé, Poodles, certain Terrier breeds, Shih-Tzu, and Old English Sheepdog.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What chemotherapeutic agent causes focal dermatologic reaction in approximately 50% of dogs

A

RAB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is the syndrome characterized by erythema, ulceration and alopecia that can occur with liposomal doxorubicin

A

Palmar-plantar erythrodysesthesia (“hand-foot syndrome”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What vitamin can reduce the severity of liposomal doxorubicin skin lesions in dogs

A

Pyridoxine (vitamin B6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

How does chemotherapy induce vomiting via the chemoreceptor trigger zone (CTZ)

A

Via neurotransmitters such as serotonin and substance P binding to 5-HT3 and neurokinin 1 (NK1) receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the mechanism of action of crofelemer in treating chemotherapy-induced diarrhea?

A

It inhibits secretion of chloride ions and water by GI epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which chemotherapy drug is primarily associated with cardiac toxicosis?

A

Doxorubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

At what cumulative dose does the risk of doxorubicin cardiac toxicity significantly increase?

A

> 180 mg/m²

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What agent can be co-administered to reduce the risk of doxorubicin cardiotoxicity

A

Dexrazoxane (an iron chelator).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Which chemotherapy drug is notably hepatotoxic in dogs, causing increased ALT in up to 86% of treated animals?

A

Lomustine (CCNU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is the nature of CCNU-induced liver damage?

A

Cumulative and often irreversible damage,
with acute liver failure rarely occurring after a single treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Name two hepatoprotectants that may reduce the severity of chemotherapy-induced liver damage

A

S-adenosylmethionine and silybin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Which chemotherapy drugs require dose adjustments with pre-existing liver disease due to biliary excretion

A

Vinca alkaloids and doxorubicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What neurologic effect can vincristine cause

A

Ileus due to neurotoxic effect on enteric motor function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Why is 5-fluorouracil contraindicated in cats

A

It can be neurotoxic and is fatal to cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Which chemotherapy drugs are known nephrotoxicants

A

Cisplatin (dogs),
ifosfamide (dogs & cats),
streptozotocin (dogs)

57
Q

Which chemotherapy drugs can cause Sterile Hemorrhagic Cystitis (SHC)

A

Cyclophosphamide and ifosfamide

58
Q

What metabolite causes direct bladder irritation leading to SHC

A

Acrolein, an inactive metabolite

59
Q

What drug is administered concurrently with high-dose cyclophosphamide to reduce the risk of SHC

A

Furosemide

60
Q

Why is cisplatin contraindicated in cats

A

It causes fatal pulmonary edema when administered IV to cats

61
Q

Which drug has been associated with diabetes in approximately 40% of cases

A

Streptozotocin (toxic to pancreatic beta cells)
Used for treatment of insulinoma

62
Q

What unusual side effects have been associated with toceranib phosphate

A

Pancreatitis and lameness

63
Q

Which drugs have been associated with pulmonary fibrosis

A

Bleomycin, high-dose CCNU in cats, and RAB

64
Q

Which chemotherapy drug can cause true IgE-mediated hypersensitivity reaction

A

L-asparaginase

65
Q

What measures can reduce the risk of hypersensitivity reactions with L-asparaginase

A

Administer SC or IM instead of IV, or premedicate with diphenhydramine

66
Q

What causes anaphylactoid reactions with rapid IV administration of doxorubicin

A

Histamine release from mast cells (not true IgE-mediated hypersensitivity)

67
Q

Melphalan

A
  • Alkylating agent (Nitrogen mustard)
  • DNA cross linking
  • Myelosupression
68
Q

Cyclophosphamide

A
  • Alkylating agent (Nitrogen mustard)
  • DNA cross-linking (prodrug)
  • Neutropenia, sterile haemorrhagic cystitis
69
Q

Ifosfamide

A
  • Alkylating agent (Nitrogen mustard)
  • DNA cross-linking (prodrug)
  • nephrotoxicity, myelosuppression, sterile haemorrhagic cystitis
70
Q

Chlorambucil

A
  • Alkylating agent (Nitrogen mustard)
  • DNA alkylation
  • Myelosupression
71
Q

Lomustine (CCNU)

A
  • Alkylating agent (nitrosoureas)
  • DNA Alkylation
  • Myelosuppression, cumulative hepatotoxicity
72
Q

Streptozotocin

A
  • Alkylating agent (nitrosoureas)
  • DNA alkylation
  • GI toxicity and myelosupression, beta cell toxicity
73
Q

Dacarbazine

A
  • Alkylating agent
  • DNA methylation
  • Gi toxicity, myelosuppression
74
Q

Procarbazine

A
  • Alkylating agent
  • DNA methylation
  • Gi toxicity and myelosuppression
75
Q

Mechlorethamine

A
  • Alkylating agent (Nitrogen mustard)
  • DNA cross linking
  • Vesicant, myelosuppression, GI toxicity
76
Q

Doxorubicin

A
  • Antitumour antibiotic
  • DNA intercalation, topoisomerase II inhibition
  • Cumulative cardiotoxicity, vesicant, myelosuppression, GI toxicity
77
Q

Mitoxantrone

A
  • Antitumour antibiotic
  • DNA intercalation, topoisomerase II inhibition
  • myelosuppression
78
Q

Actinomycin D

A
  • Antitumour antibiotic
  • DNA intercalation, RNA/protein synthesis inhibition
  • Vesicant, GI toxicity and myelosuppression
79
Q

Cytosine Arabinoside

A
  • Antimetabolite
  • DNA polymerase inhibition
  • Myelosuppression, GI toxicity
80
Q

Methotrexate

A
  • Antimetabolite
  • Dihydrofolate reductase inhibition
  • Myelosuppression, GI toxicity
81
Q

Gemcitibine

A
  • Antimetabolite
  • Nucleoside analogue, inhibits DNA synthesis
  • Myelosuppression
82
Q

5-Fluorouracil

A
  • Antimetabolite
  • Uracil analogue, Thymidylate synthetase inhibition, inhibits DNA synthesis
  • Myelosupression, GI toxicity
  • **Contraindicated in cats **
83
Q

Rabacfosadine

A
  • Antimetabolite
  • Nucleotide analogue
  • GI toxicity, **idiosyncratic pulmonary fibrosis, dermatologic **
84
Q

Paclitaxel

A
  • Antimicrotubule agent (taxane)
  • Causes abnormal organization of spindle microtubules and mitotic arrest
  • Hypersensitivity reactions, myelosuppression
85
Q

Vincristine, vinblastine, vinorelbine

A
  • Antimicrotubule agent (vinca alkaloid)
  • Microtubule assembly inhibition - metaphase arrest
  • Vincristine - Peripheral neurotoxicity, GI ileus, vesicant
  • Myelosupression, vesicant
86
Q

Carboplatin and Cisplatin

A
  • Platinum agents
  • DNA cross linking
  • Carboplatin - myelosuppression
  • Cisplatin - nephrotoxicity, GI toxicity, contraindicated in cats
87
Q

Hydroxyurea

A
  • Ribonucleotide reductase inhibition, depletion of deoxyribonucleotide
  • myeleosupression, onycholysis
88
Q

L-asparaginase

A
  • Asparagine depletion and inhibition of protein synthesis
  • Hypersensitivity reactions
89
Q

Toceranib, masitinib, imatinib

A
  • Tyrosine kinase inhibitors
  • RTK inhibition (KIT, VEGFR2, PDGFR)
  • GI toxicity, hyporexia, proteinuria/PLN, hypertension, hepatotoxicity
90
Q

Which chemotherapeutics target the S phase

A

Antimetabolites,
alkylating agents,
cross-linking agents,
topoisomerase inhibitors

91
Q

Which chemotherapeutics target the M phase

A

Antimicrotubule agents

92
Q

Which tumor type is most commonly associated with gastrointestinal ulceration
What is the mechanism

A
  • Mast cell tumours
  • Hyperhistaminemia stimulating gastric acid secretion
93
Q

Which cytokines mediate cancer cachexia?

A

TNF-α, IL-1, and IL-6

94
Q

Which canine tumors are commonly associated with hypercalcemia of malignancy?

A

T-cell lymphoma and anal sac apocrine gland adenocarcinoma

95
Q

Which feline tumors are associated with hypercalcemia of malignancy?

A

Lymphoma, squamous cell carcinoma (SCC), and multiple myeloma

96
Q

What are three tumor types associated with hypoglycemia?
What molecule typically mediates this

A

Insulinoma, hepatocellular tumors, and smooth muscle tumors
IGF-2

97
Q

Which tumor is most commonly associated with hyperestrogenism?
What are the clinical sigs

A
  • Sertoli cell tumors (especially in cryptorchid testes)
  • Feminisation and BM toxicity
98
Q

How common is anemia in dogs/cats with lymphoma?

A

Very common, reported in 30-58% of cases

99
Q

How common is thrombocytopenia in dogs with cancer before treatment?

A

Present in 13-36% of dogs

100
Q

Which neoplasm is associated with hyperglobulinemia?

A

Multiple myeloma

101
Q

Which tumor types are associated with erythrocytosis

A

Renal tumors

102
Q

What tumor is associated with nodular dermatofibrosis, and in which breed?

A

Renal cystadenocarcinomas, mostly in German shepherds

103
Q

What type of tumor is associated with superficial necrolytic dermatitis?

A

Glucagon-secreting tumors

104
Q

What tumor types are associated with feline paraneoplastic alopecia?

A

Pancreatic and biliary carcinomas

105
Q

What tumor is associated with exfoliative dermatitis in cats?

106
Q

Which tumor is most commonly associated with myasthenia gravis?

107
Q

Which tumor types are associated with hypertrophic osteopathy?

A

Primary or metastatic lung tumors

108
Q

What is the most common histopathological diagnosis in dogs with lymphoma

A

Diffuse large B cell lymphoma (DLBCL) - 50% cases

109
Q

Which subclassification of lymphoma is most liekly to cause paraneoplastic hypercalcemia

110
Q

Which dogs show a higher breed prevalacance for B cell lymphoma

A

Basset Hound, Cocker Spaniel, Border Collie, Doberman Pinscher

111
Q

Which dogs show a higher breed prevalacance for T cell lymphoma

A

Boxer, Shih Tzu, Cavalier King Charles Spaniel, Airedale

112
Q

Which breed are over represented in Indolent T-zone Lymphoma (TZL)

A

Golden retreiver ~40% cases

113
Q

What proportion of dogs with Indolent T zone lymphoma (TZL) have a concurrent blood lymphcytosis

114
Q

Which anatomical location for lymphoma is more likely to have an associated paraneoplastic hypercalcemia?

A

Mediastinal

115
Q

What is the WHO staging for lymphoma

A
  • Stage I: Single lymph node
  • Stage II: Multiple lymph nodes in a regional area (same side of diaphragm)
  • Stage III: Generalized lymphadenopathy
  • Stage IV: Liver and/or spleen involvement (± lymph node involvement)
  • Stage V: Any other anatomic site, including bone marrow and blood
  • Substage a: Without clinical signs of disease
  • Substage b: With clinical signs of disease
116
Q

What are the cluster of differentiation T cell markers?

A

CD3, CD5, CD4, CD8

117
Q

What are the cluster of differentiation B cell markers?

A

CD20, CD21, CD79a

118
Q

What is the pan-leucocyte marker

119
Q

What is the leucocyte pre-cursor marker (immature lymphoid/myeloid cells)

120
Q

Expression of MHCII is typically high or low in peripheral T cell lymphoma in dogs

121
Q

FeLV is strongly associated with which neoplastic diseases

A

Large cell lymphoma (usually T cell) and Leukaemia

122
Q

FIV infected cats are more likely to develop which type of lymphoma

A

approx 5x more likely to develop lymphoma
typically B cell in extranodal sites

123
Q

FeLV associated lymphoma is most likely foudn in which anatomical locations

A

Mediastinal lymphoma most common, followed by multicentric, spinal, renal, or ocular

GI and nasal not usually FeLV associated

124
Q

What anatomical location is most common in cats and what are the 3 types

A

Gatrointestinal
* Mucosal T cell lymphoma (EATCL Type II): small/intermediate lymphocytes in LP
* Transmural T cell lymphoma (EATCL Type I): large granular lymphocytes
* Diffuse large B cell lymphoma (DLBCL)

125
Q

What are some prognostic indicators for cats with lymphoma

A
  • Response to treatment
  • FeLV positivity - strong negative factor
  • Large granular lymphoma - aggressive variant
126
Q

What are some prognostic indicators for dogs with lymphoma

A
  • Immunophenotype: T-cell (except TZL) worse than B-cell
  • Clinical substage: b worse than a
  • Hypercalcemia: negative factor
  • GI involvement: negative factor
127
Q

What are the CD features of most chronic lymphocytic leukemias (CLL) in dogs?

A
  • At least 75% are CD8+ CD45+ T-cell in origin
  • CD21+ B-cell CLL is the next most common subtype
128
Q

What are the CD features of most chronic lymphocytic leukemias (CLL) in cats?

A
  • Almost all cases are CD4+ cell in origin
129
Q

Is CLL in cats associated with FeLV/FIV?

130
Q

What characterises acute lymphoblastic leukemia (ALL)

A
  • proliferation of immature lymphoblasts in BM
  • Diagnosis based on >20% blasts in peripheral blood or BM
131
Q

What CD marker typically distinguishes acute leukemia from lymphoma?
What proportion of dogs with ALL are negative for this marker?

A

CD34+
25% dogs with ALL are CD34-

132
Q

Is ALL in cats associated with FeLV or FIV

133
Q

What characterises Myelodysplastic syndrome?

A
  • Cytopenias in multiple cell lines
  • Bone marrow usually normocellular to hypercellular with dysplastic changes
  • Increased blasts but <20% of nucleated cells
134
Q

What characterises multiple myeloma

A

Arises from single clone of plasma cells producing excess immunoglobulin (can be whole Ig moelcule or molecular portion)

135
Q

What are some of the characteristic clinical findings with multiple myeloma

A
  • Other cytopenias (anaemia, thrombocytopenia and sometimes neutropenia)
  • Bone lesion with dicrete osteolytic painful areas (vertebrae, ribs, pelvis, long bones)
  • Coagulation and bleeding disorders
  • Excess light chains (bence jones proteins) can cause renal damage
136
Q

What are the diagnostic criteria for multiple myeloma

A

Need>/=2
* BM plasmacytosis (>20%)
* Serum monoclonal gammopathy
* Osteolytic lesions
* Bence-Jones proteinuria

137
Q

What is BRAF

A

a gene and associated protein that helps control cell growth

138
Q

What is the BRAF mutation and what disease can it help identify

A
  • Specific mutation detected is called BRAF V595E
  • More than 80% of dogs with transitional cell carcinoma (TCC) have this BRAF V595E mutation
139
Q

What is the sensitivity and specificity of BRAF

A

Testing has >85% sensitivity with 100% specificity when used on free-catch urine samples